Products Products
Mutual Funds
Stock Market
NPS Retirement Funds

Company Company
About us
Contact us
1000001571
Paytm
Mutual Funds Stock Market NPS Retirement Funds
About us Contact us

Suven Pharmaceuticals

1137.10
+0.70 (0.06%) tick NSE

Buy Sell

Last updated on 1 May 2025 04:12 PM

Returns
-5.70%
Loading chart...

Fundamentals

Large Cap

Financial - Banking

Market Cap (Cr)

28877.85

Earning Per Share

11.97

Dividend Yield

-%

P/E Ratio

56.52

P/B Ratio

13.09

Debt to Equity

0.04

Performance

min-value
max-value

Open

56,601.30

52-wk High

75,250.00

High

56,601.30

52-wk Low

75,250.00

Low

56,601.30

Band

75,250.00

Lower Circuit

56,601.30

Upper Circuit

75,250.00

Volume

56,601.30

VWAP

75,250.00

52 Week Performance

min-value
max-value
down-img

5.34% down side

up side5.34%

ups-img

About the company

Suven Pharmaceuticals Limited (SPL) is an integrated Contract Development and Manufacturing Operations (CDMO) company that serves leading global life science and fine chemical majors. The Company's comprehensive services encompass- Custom Synthesis, Process R&D, Scale-Up, and Contract Manufacturing of intermediates, APIs, and formulations. Suven Pharmaceuticals Limited was incorporated on 6 November, 2018 and is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies. The Company has established core competencies in cyanation and heterocyclic chemistry, covering pyrimidines, quinolones, thiazoles, and imidazoles. The Company is a CDMO that supports global life sciences industry and fine chemical majors in their NCE development endeavors.

Similar Companies


Login